Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

National health projections through 2008.

S Smith1, S K Heffler, S Calfo

  • 1Office of the Actuary, Health Care Financing Administration, Baltimore, MD 21244-1850, USA. ssmith2@hcfa.gov

Health Care Financing Review
|August 3, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HER2-directed therapy following ctDNA-identified <i>ERBB2</i> amplification in patients with advanced gastroesophageal cancer: exploration of real-world outcomes.

ESMO gastrointestinal oncology·2026
Same author

Author Correction: Anti-HEV seroprevalence and rate of viremia in a German cohort of dogs, cats, and horses.

Scientific reports·2023
Same author

Anti-HEV seroprevalence and rate of viremia in a German cohort of dogs, cats, and horses.

Scientific reports·2023
Same author

High-throughput quantitative method for assessing coaggregation among oral bacterial species.

Letters in applied microbiology·2016
Same author

Clinical experience with Leptospermum honey use for treatment of hard to heal neonatal wounds: case series.

Journal of perinatology : official journal of the California Perinatal Association·2014
Same author

Effects of agrobacterial oncogenes in kidney vetch (Anthyllis vulneraria L.).

Plant cell reports·2013
Same journal

Health Care Indicators.

Health care financing review·2014
Same journal

Achieving cost control in the hospital outpatient department.

Health care financing review·2014
Same journal

Age Estimates in the National Health Accounts.

Health care financing review·2014
Same journal

Managed care: Practice, pitfalls, and potential.

Health care financing review·2014
Same journal

Overview.

Health care financing review·2014
Same journal

Research Issues: Dually Eligible Medicare and Medicaid Beneficiaries, Challenges and Opportunities.

Health care financing review·2014
See all related articles

US health spending will increase as a share of gross domestic product (GDP), doubling to $2.2 trillion by 2008. Private health spending is projected to accelerate, while Medicare spending growth is expected to slow due to the Balanced Budget Act of 1997.

Area of Science:

  • Health Economics
  • Public Health Policy

Background:

  • US health spending experienced near stability as a share of GDP for six years (1997-2003).
  • Projected trends indicate a significant increase in health expenditures relative to economic output.

Purpose of the Study:

  • To project future trends in US health spending as a share of GDP.
  • To analyze shifts in public versus private healthcare expenditure growth patterns.

Main Methods:

  • Analysis of historical health spending data (1997-2003).
  • Projection modeling for health spending up to 2008.
  • Evaluation of the impact of the Balanced Budget Act of 1997 on Medicare spending.

Main Results:

  • Health spending is projected to rise from 13.5% of GDP in 1997 to 16.2% by 2008.

Related Experiment Videos

  • Total US health spending is expected to double from $1.1 trillion in 1997 to $2.2 trillion by 2008.
  • A reversal in growth patterns is anticipated, with accelerated private spending and slowed Medicare spending.
  • Conclusions:

    • US healthcare spending is set to increase significantly as a proportion of the national economy.
    • Policy interventions, such as the Balanced Budget Act, are expected to reshape healthcare spending dynamics.
    • Anticipated acceleration in private health spending may offset slowed public sector growth.